Skip to main content
. 2021 Feb 26;16:103. doi: 10.1186/s13023-021-01693-9

Fig. 1.

Fig. 1

Study algorithm. Infants with a positive newborn screening (NBS) test came from different primary care health centers. The clinical and biochemical approach of the 84 unrelated individuals initially referred to our center as G6PDd started with a new measurement of the G6PD activity in dried blood spots (DBS) and further G6PD genotyping experiments that unequivocally confirmed the G6PDd status in 81 patients, with or without neonatal jaundice (NNJ)